Lindbrook Capital, LLC Applied Genetic Technologies Corp Transaction History

Lindbrook Capital, LLC

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 27, 2020
SELL
$3.0 - $6.9 $1,500 - $3,450
-500 Closed
0 $0
Q1 2020

Apr 22, 2020
SELL
$2.36 - $9.86 $2,360 - $9,860
-1,000 Reduced 66.67%
500 $2,000
Q4 2019

Jan 27, 2020
BUY
$2.69 - $4.92 $4,035 - $7,380
1,500 New
1,500 $7,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email